II. Indications: Non-invasively assess trisomy risk
- Maternal age over 35 years
III. Efficacy
- Trisomy risk Age >35 years
- Overall: 1 in 80
- With Negative Ultrasound: 1 in 400
-
Ultrasound detects
- Trisomy 18: 100%
- Trisomy 21 Test Sensitivity: 50-60%
- Least accurate screening for Aneuploidy
- Follow positive Ultrasound testing with Second Trimester Quad Screening or Placental Cell-Free DNA
IV. Findings: Soft Markers of Aneuploidy on Second Trimester Ultrasound
V. Screening: Rating system to assess for Trisomy
- Scoring
- Nuchal Fold (5mm)
- Assess at level of Cerebellum and cisterna magna
- Not predictive after 21 weeks
- 2 Points
- Short femur length
- 1 Point
- Cystic Hygroma
- Seen in Turners Syndrome, Trisomy 21, Idiopathic
- 1 Point
- Septal defect or other heart defect
- 1 Point
- Choroid plexus cyst
- 1 Point
- Nuchal Fold (5mm)
- Interpretation: Score associated with Trisomy risk
- Age <35: Score >= 2 points
- Age >35: Score >= 1 point
VI. Evaluation: Findings suggestive of Trisomy
- See Antenatal Screening
- See Aneuploidy Screening
- Consider Placental Cell-Free DNA
- Consider Amniocentesis with karyotype